Constant v. Wyeth

352 F. Supp. 2d 847, 2003 U.S. Dist. LEXIS 12786, 2003 WL 23977200
CourtDistrict Court, M.D. Tennessee
DecidedApril 9, 2003
DocketCIV. 3:03-0052
StatusPublished
Cited by12 cases

This text of 352 F. Supp. 2d 847 (Constant v. Wyeth) is published on Counsel Stack Legal Research, covering District Court, M.D. Tennessee primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Constant v. Wyeth, 352 F. Supp. 2d 847, 2003 U.S. Dist. LEXIS 12786, 2003 WL 23977200 (M.D. Tenn. 2003).

Opinion

MEMORANDUM

TRAUGER, District Judge.

Pending before the court are two motions. The plaintiff has filed a Motion to Remand this case to the Davidson County Circuit Court, from which the Wyeth defendants removed it. (Docket No. 18) This *849 motion is opposed by the Wyeth defendants (Docket No. 20), but no response has been filed by defendant James W. Johnson, M.D. 1 The second motion is defendant Dr. Johnson’s Motion to Dismiss (Docket No. 13), to which the plaintiff has responded in opposition. (Docket No. 17) Following the initial case management conference on March 31, 2003, all parties filed supplemental briefs. (Docket Nos. 27-29)

Relevant Factual Background 2

In 1997, the plaintiff went to defendant James W. Johnson, M.D. to seek help with weight management. Dr. Johnson prescribed for her Pondomin and Phentera-mine (“Fen-Phen”), which she took for several months.

In September 1997, Fen-Phen was taken off the market because of concerns about serious health effects. Lawsuits were filed across the country, and the federal cases were consolidated as multi-dis-trict litigation in the United States District Court for the Eastern District of Pennsylvania. A settlement was reached in the MDL case, and the plaintiff executed an “opt-out” form in March of 2000 that preserved her individual right to bring suit in connection with any injuries sustained by the ingestion of Fen-Phen (First Amended Complaint, ¶ 1; Docket No. 19 at 12).

The plaintiff filed suit in state court on December 12, 2002 and filed her First Amended Complaint on January 2, 2003. The Wyeth defendants removed the case to this court on January 15, 2003. (Docket No. 1) Codefendant james W. Johnson, M.D. did not join in the Notice of Removal.

Motion to Remand

Under the removal statute, 28 U.S.C. § 1446, all defendants must join in a notice of removal. Michigan Affiliated Healthcare v. CC Systems, 139 F.3d 546, 549 (6th Cir.1998). Where, however, a defendant is fraudulently joined in order to defeat diversity jurisdiction, the court may disregard the citizenship of that defendant, and its failure to consent to the removal, in determining whether diversity jurisdiction exists. Coyne v. America Tobacco Co., 183 F.3d 488, 493 (6th Cir.1999). Here, the Wyeth defendants maintain that defendant James W. Johnson, M.D., who was a citi- ■ zen of Tennessee (as is the plaintiff), has been fraudulently joined in order to defeat diversity jurisdiction. 3 (Docket No. 1)

The removing party bears the burden of establishing federal jurisdiction and, therefore, whether a non-diverse defendant has been fraudulently joined. All disputed questions of fact and “ambiguities in the controlling state law” are to be resolved in favor of the non-removing party. Removal statutes are to be strictly construed. Alexander v. Electronic Data Systems Corp., 13 F.3d 940, 948 (6th Cir.1994) (internal citations omitted)(emphasis in original). If there is a “colorable basis for predicting that a plaintiff may recover against non-diverse defendants,” the case “must” be remanded to state court. Coyne, supra, at 493; Jerome-Duncan, Inc. v. Auto-By-Tel, L.L.C., 176 F.3d 904, 907 (6th Cir.1999); Alexander, supra, at 949.

*850 1. Medical Malpractice Claim

The plaintiffs First Amended Complaint (Docket No. 1, attach., Ex. I) alleges that she has sustained injury as a result of taking Fen-Phen, which was prescribed by defendant Johnson for weight loss in 1997. She alleges medical malpractice under the Tennessee statute and a violation of the Tennessee Consumer Protection Act (“TCPA”) against Dr. Johnson and numerous other causes of action against the Wyeth defendants. The Wyeth defendants (and defendant Johnson in his Motion to Dismiss) allege that the statute of limitations and/or the statute of repose have run on all claims against Dr. Johnson and that, therefore, there cannot be a valid, “colorable” claim against Dr. Johnson that would defeat diversity jurisdiction and mandate a remand of the case to state court.

The statute of limitations for a Tennessee medical malpractice claim provides, in part, as follows:

(1) The statute of limitations in malpractice actions shall be one (1) year as set forth in § 28-3-104. 4
(2) In the event the alleged injury is not discovered within such one (1) year period, the period of limitations shall be one (1) year from the date of such discovery.
(3) In no event shall any such action be brought more than three (3) years after the date on which the negligent action or omission occurred except where there is fraudulent concealment on the part of the defendant, in which case the action shall be commenced within one (1) year after discovery that the cause of action exists.

Tenn.Code. Ann. § 29-26-116(a) (emphasis added).

The plaintiff asserts that she “had no indication or reason to believe that she had actually suffered any adverse effects as a result of her ingestion of those drugs until December 2001, and that diagnosis was not confirmed until early 2002.” (Docket No. 19 at 9) 5 Because she brought suit on December 12, 2002, the plaintiff may have met the requirement in Tenn.Code. Ann. § 29-26-116(a)(2) that suit be brought within one year of the date of discovery. However, even if she has, the plaintiff still must comply with the medical malpractice statute of repose, which forecloses any action from being brought more than three years after the date of the negligent act, unless there has been “fraudulent concealment on the part of the defendant.” Tenn. Code. Ann. § 29-26-116(a)(3). Since the acts of malpractice on the part of Dr. Johnson had to have occurred in 1997, when he prescribed Fen-Phen for the plaintiff, she would have had to have brought an action against him by sometime in the year 2000 in order to be within the statute of repose. She did not sue until December of 2002, so in order to be relieved of the statute of repose time limitation, she must establish fraudulent concealment on the part of Dr. Johnson.

The plaintiff bears the burden of proof as to fraudulent concealment. Benton v. Snyder, 825 S.W.2d 409, 414 (Tenn.1992). The plaintiff must establish:

(1) the healthcare provider took affirmative action to conceal the wrongdoing *851

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Investigation Of Law Solutions Chicago, LLC
Court of Appeals of Tennessee, 2021
Roy Franks v. Tiffany Sykes
Tennessee Supreme Court, 2020
Roy Franks v. Tiffany Sykes
Court of Appeals of Tennessee, 2018
Wright v. Linebarger Googan Blair & Sampson, LLP
782 F. Supp. 2d 593 (W.D. Tennessee, 2011)
Proctor v. Chattanooga Orthopaedic Group, P.C.
270 S.W.3d 56 (Court of Appeals of Tennessee, 2008)
Feild v. GRAFFAGNINO
514 F. Supp. 2d 1036 (W.D. Tennessee, 2007)
Roberson v. Medtronic, Inc.
494 F. Supp. 2d 864 (W.D. Tennessee, 2007)
Anderson v. Merck & Co. Inc.
417 F. Supp. 2d 842 (E.D. Kentucky, 2006)
Weiss v. Fujisawa Pharmaceutical Co.
415 F. Supp. 2d 720 (E.D. Kentucky, 2005)
Cordle v. Merck & Co., Inc.
405 F. Supp. 2d 800 (E.D. Kentucky, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
352 F. Supp. 2d 847, 2003 U.S. Dist. LEXIS 12786, 2003 WL 23977200, Counsel Stack Legal Research, https://law.counselstack.com/opinion/constant-v-wyeth-tnmd-2003.